CHIP Protects from the Neurotoxicity of Expanded and Wild-type Ataxin-1 and Promotes Their Ubiquitination and Degradation*
- Ismael Al-Ramahi‡§,
- Yung C. Lam¶,
- Hung-Kai Chen‡,
- Beatrice de Gouyon‡,
- Minghang Zhang‡,
- Alma M. Pérez‡,
- Joana Branco‡,1,
- Maria de Haro‡§,
- Cam Patterson∥,
- Huda Y. Zoghbi‡¶,**,2 and
- Juan Botas‡,3
- ‡Departments of Molecular and Human Genetics and ¶Neuroscience, **Howard Hughes Medical Institute, Baylor College of Medicine, Houston, Texas 77030, the ∥Carolina Cardiovascular Biology Center and Departments of Medicine, Pharmacology, and Cell and Developmental Biology, University of North Carolina, Chapel Hill, North Carolina 27599, and the§Departamento de Biología, Facultad de Ciencias-University Autonoma de Madrid, Madrid 28049, Spain
- ↵3 To whom correspondence should be addressed. Tel.: 713-798-5937; Fax: 713-798-8142; E-mail: jbotas{at}bcm.tmc.edu.
Abstract
CHIP (C terminus of Hsc-70 interacting protein) is an E3 ligase that links the protein folding machinery with the ubiquitin-proteasome system and has been implicated in disorders characterized by protein misfolding and aggregation. Here we investigate the role of CHIP in protecting from ataxin-1-induced neurodegeneration. Ataxin-1 is a polyglutamine protein whose expansion causes spinocerebellar ataxia type-1 (SCA1) and triggers the formation of nuclear inclusions (NIs). We find that CHIP and ataxin-1 proteins directly interact and co-localize in NIs both in cell culture and SCA1 postmortem neurons. CHIP promotes ubiquitination of expanded ataxin-1 both in vitro and in cell culture. The Hsp70 chaperone increases CHIP-mediated ubiquitination of ataxin-1 in vitro, and the tetratricopeptide repeat domain, which mediates CHIP interactions with chaperones, is required for ataxin-1 ubitiquination in cell culture. Interestingly, CHIP also interacts with and ubiquitinates unexpanded ataxin-1. Overexpression of CHIP in a Drosophila model of SCA1 decreases the protein steady-state levels of both expanded and unexpanded ataxin-1 and suppresses their toxicity. Finally we investigate the ability of CHIP to protect against toxicity caused by expanded polyglutamine tracts in different protein contexts. We find that CHIP is not effective in suppressing the toxicity caused by a bare 127Q tract with only a short hemaglutinin tag, but it is very efficient in suppressing toxicity caused by a 128Q tract in the context of an N-terminal huntingtin backbone. These data underscore the importance of the protein framework for modulating the effects of polyglutamine-induced neurodegeneration.
- Received February 21, 2006.
- Revision received July 5, 2006.
- The American Society for Biochemistry and Molecular Biology, Inc.











